ARTELO BIOSCIENCES, INC. Public Float
ARTELO BIOSCIENCES, INC. (ARTL) had Public Float of $9.29 million as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $9.29M.
- 2024-06-30: Entity Public Float $4.29M.
- 2023-06-30: Entity Public Float $5.63M.
- 2022-06-30: Entity Public Float $13.69M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $9.29M 10-K · filed 2026-02-24 | |
| 2024-06-30 | $4.29M 10-K · filed 2025-03-03 | |
| 2023-06-30 | $5.63M 10-K · filed 2024-03-25 | |
| 2022-06-30 | $13.69M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $28.50M 10-KT · filed 2022-03-21 | |
| 2021-02-26 | $39.89M 10-K · filed 2021-11-29 | |
| 2020-02-29 | $2.97M 10-K · filed 2020-11-04 | |
| 2019-02-28 | $12.81M 10-K/A · filed 2019-12-18 | $12.17M 10-K · filed 2019-11-25 |
| 2018-02-28 | $9.50M 10-K · filed 2018-11-29 | |
| 2017-02-28 | $199.62K 10-K · filed 2017-11-29 | |
| 2015-02-28 | $0.00 10-K · filed 2016-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |